WealthBridge Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.16M Buy
5,605
+25
+0.4% +$25.3K 1.19% 18
2025
Q4
$6M Sell
5,580
-95
-2% -$90.8K 1.37% 16
2025
Q3
$4.33M Sell
5,675
-183
-3% -$136K 1.02% 23
2025
Q2
$4.57M Buy
5,858
+155
+3% +$120K 1.16% 19
2025
Q1
$4.71M Buy
5,703
+187
+3% +$156K 1.33% 19
2024
Q4
$4.26M Buy
5,516
+267
+5% +$221K 1.18% 21
2024
Q3
$4.65M Buy
5,249
+1,876
+56% +$1.69M 1.33% 18
2024
Q2
$3.05M Buy
3,373
+100
+3% +$80K 1% 23
2024
Q1
$2.55M Buy
3,273
+181
+6% +$129K 0.86% 26
2023
Q4
$1.8M Buy
3,092
+478
+18% +$279K 0.68% 35
2023
Q3
$1.4M Buy
2,614
+587
+29% +$302K 0.58% 39
2023
Q2
$951K Buy
2,027
+489
+32% +$205K 0.38% 58
2023
Q1
$528K Buy
1,538
+735
+92% +$248K 0.21% 96
2022
Q4
$294K Buy
+803
New +$285K 0.12% 150
2019
Q2
Sell
-130
Closed -$15K 537
2019
Q1
$15K Buy
130
+71
+120% +$8.63K 0.01% 491
2018
Q4
$7K Buy
+59
New +$6.59K 0.01% 583

Other funds holding LLY

WealthBridge Capital Management's LLY Position: Q1 2026 in Review

WealthBridge Capital Management increased its Eli Lilly (LLY) stake by 0.45% in Q1 2026, buying an estimated $25.3K and bringing the position to 5,605 shares worth $5.16M. The position accounts for 1.19% of the portfolio, ranked #18.

WealthBridge Capital Management first reported a position in LLY in Q4 2018 and has held it in 16 quarters since. The position peaked at $6M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • WealthBridge Capital Management held 5,605 shares of Eli Lilly worth $5.16M as of Q1 2026.
  • WealthBridge Capital Management bought 25 Eli Lilly shares in Q1 2026, an estimated $25.3K.
  • Eli Lilly made up 1.19% of WealthBridge Capital Management's portfolio in Q1 2026, its #18 holding.
  • WealthBridge Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 16 quarters since.
  • WealthBridge Capital Management's Eli Lilly position peaked at $6M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on WealthBridge Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.